Abstract:Background: Adjuvant therapy for patients with cervical cancer (CC) with intermediate-risk factors remains controversial. The objectives of the present study are to assess the prognoses of patients with early-stage CC with pathological intermediate-risk factors and to provide a reference for adjuvant therapy choice. Materials and methods: This retrospective study included 481 patients with stage IB-IIA CC. Cox proportional hazards regression analysis, machine learning (ML) algorithms, Kaplan-Meier analysis, and the area under the receiver operating characteristic curve (AUC) were used to develop and validate prediction models for disease-free survival (DFS) and overall survival (OS). Results: A total of 35 (7.3%) patients experienced recurrence, and 20 (4.2%) patients died. Two prediction models were built for DFS and OS using clinical information, including age, lymphovascular space invasion, stromal invasion, tumor size, and adjuvant treatment. Patients were divided into high-risk or low-risk groups according to the risk score cutoff value. The Kaplan-Meier analysis showed significant differences in DFS (p = .001) and OS (p = .011) between the two risk groups. In the traditional Sedlis criteria groups, there were no significant differences in DFS or OS (p > .05). In the ML-based validation, the best AUCs of DFS at 2 and 5 years were 0.69/0.69, and the best AUCs of OS at 2 and 5 years were 0.88/0.63. Conclusion: Two prognostic assessment models were successfully established, and risk grouping stratified the prognostic risk of patients with CC with pathological intermediate-risk factors. Evaluation of long-term survival will be needed to corroborate these findings. Implications for practice: The Sedlis criteria are intermediate-risk factors used to guide postoperative adjuvant treatment in patients with cervical cancer. However, for patients meeting the Sedlis criteria, the choice of adjuvant therapy remains controversial. This study developed two prognostic models based on pathological intermediate-risk factors. According to the risk score obtained by the prediction model, patients can be further divided into groups with high or low risk of recurrence and death. The prognostic models developed in this study can be used in clinical practice to stratify prognostic risk and provide more individualized adjuvant therapy choices to patients with early-stage cervical cancer.

Predictive models for personalized precision medical intervention in spontaneous regression stages of cervical precancerous lesions

A multi-variable predictive warning model for cervical cancer using clinical and SNPs data

Predicting cervical intraepithelial neoplasia and determining the follow-up period in high-risk human papillomavirus patients

Evaluating the Feasibility of Machine-Learning-Based Predictive Models for Precancerous Cervical Lesions in Patients Referred for Colposcopy

A Personalized Computational Model Predicts Cancer Risk Level of Oral Potentially Malignant Disorders and Its Web Application for Promotion of Non-Invasive Screening.

Novel artificial intelligence machine learning approaches to precisely predict survival and site-specific recurrence in cervical cancer: A multi-institutional study

[Precision screening and treatment of human papilloma virus related cervical cancer]

Machine Learning Prediction of Residual and Recurrent High-Grade CIN Post-LEEP

Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer

Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China

Development of models for cervical cancer screening: construction in a cross-sectional population and validation in two screening cohorts in China

Practical Model for Residual/Recurrent Cervical Intraepithelial Lesions in Patients with Negative Margins after Cold-Knife Conization.

Assessing the risk of high-grade squamous intraepithelial lesions (HSIL+) in women with LSIL biopsies: a machine learning-based study

Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm

Biomarkers differentiating regression from progression among untreated cervical intraepithelial neoplasia grade 2 lesions

Human Papillomavirus DNA, HPV L1 Capsid Protein and P16(ink4a) Protein As Markers to Predict Cervical Lesion Progression

Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China

Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.

Prediction Models of Colorectal Cancer Prognosis Incorporating Perioperative Longitudinal Serum Tumor Markers: a Retrospective Longitudinal Cohort Study

Application of Machine Learning Algorithms for Risk Stratification and Efficacy Evaluation in Cervical Cancer Screening Among the ASCUS/LSIL Population: Evidence from the Korean HPV Cohort Study

Development of a clinical prediction model for pathological upgrading in low-grade squamous intraepithelial lesions following cervical conization